References
- LewisATorvinenSDekhuijzenPNThe economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countriesBMC Health Serv Res20161625127406133
- Asthma UKAsthma facts and statistics Available from: https://www.asthma.org.uk/about/media/facts-and-statistics/Accessed February 12, 2018
- World Health OrganizationChronic respiratory diseases Available from: http://www.who.int/respiratory/en/Accessed October 26, 2017
- SteinSWThielCGThe history of therapeutic aerosols: a chronological reviewJ Aerosol Med Pulm Drug Deliv2017301204127748638
- LavoriniFCorriganCJBarnesPJAerosol Drug Management Improvement TeamRetail sales of inhalation devices in European countries: so much for a global policyRespir Med201110571099110321489771
- RoguedaPTrainiDThe future of inhalers: how can we improve drug delivery in asthma and COPD?Expert Rev Respir Med201610101041104427545190
- BraidoFChrystynHBaiardiniIRespiratory Effectiveness Group“Trying, but failing” – the role of inhaler technique and mode of delivery in respiratory medication adherenceJ Allergy Clin Immunol Pract20164582383227587316
- LavoriniFFontanaGAUsmaniOSNew inhaler devices – the good, the bad and the uglyRespiration201488131524902629
- Dudvarski IlicAZugicVZvezdinBInfluence of inhaler technique on asthma and COPD control: a multicenter experienceInt J Chron Obstruct Pulmon Dis2016112509251727785007
- Global Initiative for AsthmaGINA Report: Global Strategy for Asthma Management and Prevention Available from: http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/Accessed August 1, 2017
- PriceDBRomán-RodríguezMMcQueenRBInhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomesJ Allergy Clin Immunol Pract2017541071108128286157
- BrandstetterSFingerTFischerWDifferences in medication adherence are associated with beliefs about medicines in asthma and COPDClin Transl Allergy201773929152167
- VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
- SulaimanICushenBGreeneGObjective assessment of adherence to inhalers by patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2017195101333134327409253
- MelaniASBonaviaMCilentiVGruppo Educazionale Associ-azione Italiana Pneumologi OspedalieriInhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
- MolimardMRaherisonCLignotSChronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patientsEur Respir J2017492160179428182569
- UsmaniOSLavoriniFMarshallJCritical inhaler errors in asthma and COPD: a systematic review of impact on health outcomesRespir Res20181911029338792
- PressVGAroraVMShahLMTeaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trialJ Gen Intern Med201227101317132522592354
- DekhuijzenPNLavoriniFUsmaniOSPatients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Patient Prefer Adherence2016101561157227574405
- ChorãoPPereiraAMFonsecaJAInhaler devices in asthma and COPD – an assessment of inhaler technique and patient preferencesRespir Med2014108796897524873873
- Inhaler Error Steering CommitteePriceDBosnic-AnticevichSInhaler competence in asthma: common errors, barriers to use and recommended solutionsRespir Med20131071374623098685
- BoniniMUsmaniOSThe importance of inhaler devices in the treatment of COPDCOPD Res Pract2015119
- Bosnic-AnticevichSChrystynHCostelloRWThe use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomesInt J Chron Obstruct Pulmon Dis201612597128053517
- PriceDBColiceGIsraelEAdd-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerERJ Open Res2016220010627730200
- LavoriniFUsmaniOSCorrect inhalation technique is critical in achieving good asthma controlPrim Care Respir J201322438538624270367
- TaffetGEDonohueJFAltmanPRConsiderations for managing chronic obstructive pulmonary disease in the elderlyClin Interv Aging20149233024376347
- YawnBPColiceGLHodderRPractical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care settingInt J Chron Obstruct Pulmon Dis2012749550222888221
- WachtelHKattenbeckSDunneSThe Respimat(®) development story: patient-centered innovationPulm Ther2017319
- BowlesSKSketrisIKephartGDrug Evaluation Alliance of Nova ScotiaUse of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors’ Pharmacare Program in Nova Scotia, CanadaAm J Geriatr Pharmacother20075212012817719514
- CatesCJWelshEJRoweBHHolding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthmaCochrane Database Syst Rev20139CD000052
- LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all cause readmissionsAnn Am Thorac Soc20171481305131128406710
- BusinessWireSunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD Available from: https://www.businesswire.com/news/home/20171205006502/en/Sunovion-Receives-FDA-Approval-Lonhala%E2%84%A2-Magnair%E2%84%A2-InhalationAccessed February, 2018
- UsmaniOSTreating the small airwaysRespiration201284644145323154684
- SonnappaSMcQueenBPostmaDSExtrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studiesJ Allergy Clin Immunol Pract Epub2017920
- SonnappaSMartinRIsraelERespiratory Effectiveness Group, Small Airways Study GroupRisk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroidsPLoS One2017126e017811228617814
- LevyMLDekhuijzenPNBarnesPJInhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)NPJ Prim Care Respir Med2016261601727098045
- DalbyRNEicherJZierenbergBDevelopment of Respimat(®) Soft Mist™ inhaler and its clinical utility in respiratory disordersMed Devices (Auckl)2011414515522915941
- LavoriniFPistolesiMUsmaniOSRecent advances in capsule-based dry powder inhaler technologyMultidiscip Respir Med2017121128536654
- MuralidharanPHayesDJrMansourHMDry powder inhalers in COPD, lung inflammation and pulmonary infectionsExpert Opin Drug Deliv201512694796225388926
- RauJLPractical problems with aerosol therapy in COPDRespir Care200651215817216441960
- Al-ShowairRATarsinWYAssiKHPearsonSBChrystynHCan all patients with COPD use the correct inhalation flow with all inhalers and does training help?Respir Med2007101112395240117629471
- BorgströmLAskingLLipniunasPAn in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditionsJ Aerosol Med200518330431016181005
- GandertonDTargeted delivery of inhaled drugs: current challenges and future goalsJ Aerosol Med199912Suppl 1S3S810623339
- Moroni-ZentgrafPImpact of patient needs on design and usage of an inhalation device in respiratory medicineRespir Drug Deliv20131141
- AndersonPUse of Respimat Soft Mist inhaler in COPD patientsInt J Chron Obstruct Pulmon Dis20061325125918046862
- Dal NegroRWLongoPZianiOVBonadimanLTurcoPInstant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench studyMultidiscip Respir Med2017121328560037
- Dal NegroRWPoveroMAcceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patientsMultidiscip Respir Med201611726865979
- BrandPHedererBAustenGDewberryHMeyerTHigher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor techniqueInt J Chron Obstruct Pulmon Dis20083476377019281091
- PedersenSDubusJCCromptonGKADMIT Working GroupThe ADMIT series – issues in inhalation therapy. 5) Inhaler selection in children with asthmaPrim Care Respir J201019320921620640390
- VinckenWDekhuijzenPRBarnesPADMIT GroupThe ADMIT series – issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010191102019890594
- NormansellRKewKMMathioudakisAGInterventions to improve inhaler technique for people with asthmaCochrane Database Syst Rev20173CD01228628288272
- FinkJBRubinBKProblems with inhaler use: a call for improved clinician and patient educationRespir Care2005501013741375
- AriAFinkJBGuidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapyExpert Rev Respir Med20115456157221859275
- MelaniASBracciLSRossiMReduced peak inspiratory effort through the Diskus(®) and the Turbuhaler(®) due to mishandling is common in clinical practiceClin Drug Investig2005258543549
- KaminWFrankMKattenbeckSMoroni-ZentgrafPWachtelHZielenSA handling study to assess use of the Respimat(®) Soft Mist™ inhaler in children under 5 years oldJ Aerosol Med Pulm Drug Deliv201528537238125844687
- WesterikJACarterVChrystynHCharacteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care settingJ Asthma201653332132926810934
- LevyMLHardwellAMcKnightEHolmesJAsthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysisPrim Care Respir J201322440641124042172
- HodderRPriceDPatient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
- PerrielloEASobierajDMThe Respimat Soft Mist inhaler, a novel inhaled drug delivery deviceConn Med201680635936427509644
- DarbàJRamírezGSicrasAFrancoliPTorvinenSSánchez-de la RosaRThe importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patientsInt J Chron Obstruct Pulmon Dis2015102335234526604733
- UsmaniOSSmall-airway disease in asthma: pharmacological considerationsCurr Opin Pulm Med2015211556725415404
- ScichiloneNAsthma control: the right inhaler for the right patientAdv Ther201532428529225845769
- VerbanckSGhorbaniaslGBiddiscombeMFInhaled aerosol distribution in human airways: a scintigraphy-guided study in a 3D printed modelJ Aerosol Med Pulm Drug Deliv201629652553327337643
- VerbanckSKalsiHSBiddiscombeMFInspiratory and expiratory aerosol deposition in the upper airwayInhal Toxicol201123210411121309663
- UsmaniOSBiddiscombeMFBarnesPJRegional lung deposition and bronchodilator response as a function of beta2-agonist particle sizeAm J Respir Crit Care Med2005172121497150416192448
- SmallMAndersonPVickersAKaySFermerSImportance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomesAdv Ther201128320221221331556
- JahediLDownieSRSainiBChanHKBosnic-AnticevichSInhaler technique in asthma: how does it relate to patients’ preferences and attitudes toward their inhalers?J Aerosol Med Pulm Drug Deliv2017301425227676193
- MiravitllesMMontero-CaballeroJRichardFA cross-sectional study to assess inhalation device handling and patient satisfaction in COPDInt J Chron Obstruct Pulmon Dis20161140741527013871
- SchürmannWSchmidtmannSMoroniPMasseyDQidanMRespimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med200541536115725050
- HodderRReesePRSlatonTAsthma patients prefer Respimat Soft Mist Inhaler to TurbuhalerInt J Chron Obstruct Pulmon Dis2009422523219554196
- LenneyJInnesJACromptonGKInappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICIRespir Med200094549650010868714
- MolimardMColthorpePInhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitionersJ Aerosol Med Pulm Drug Deliv201528321922825265316
- CromptonGKBarnesPJBroedersMAerosol Drug Management Improvement TeamThe need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement TeamRespir Med200610091479149416495040
- LavoriniFLevyMLCorriganCCromptonGADMIT Working GroupThe ADMIT series – issues in inhalation therapy. 6) Training tools for inhalation devicesPrim Care Respir J201019433534121049263
- MelaniASZanchettaDBarbatoNAssociazione Italiana Pneumologi Ospedalieri Educational GroupInhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adultsAnn Allergy Asthma Immunol200493543944615562882
- BashetiIAReddelHKArmourCLBosnic-AnticevichSZCounseling about turbuhaler technique: needs assessment and effective strategies for community pharmacistsRespir Care200550561762315871755
- Bosnic-AnticevichSZSinhaHSoSReddelHKMetered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over timeJ Asthma201047325125620394511
- GoodwinRChanderTShahNTomlinSInhaler counselling, the real deal or just fresh air?Arch Dis Child20161019e2
- LeungJBhutaniMLeighRPelletierDGoodCSinDDEmpowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthmaCan Respir J201522526627026436910
- MulhallAMZafarMARecordSChannellHPanosRJA tablet-based multimedia education tool improves provider and subject knowledge of inhaler use techniquesRespir Care201762216317128108685
- TakakuYKurashimaKOhtaCHow many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?Respir Med201712311011528137486
- BashetiIAObeidatNMReddelHKEffect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: a single-blind randomized controlled trialNPJ Prim Care Respir Med2017271928184045
- GoodwinRHeraghtyJDo healthcare professionals understand asthma devices?Arch Dis Child Educ Pract Ed2015100630230526407731
- HouSWuJLiXShuHPractical, regulatory and clinical considerations for development of inhalation drug productsAsian J Pharm Sci201510490500
- SimpsonAJHonkoopPJKenningtonEPerspectives of patients and healthcare professionals on mHealth for asthma self-managementEur Respir J2017495160196628461291
- KikidisDKonstantinosVTzovarasDUsmaniOSThe digital asthma patient: the history and future of inhaler based health monitoring devicesJ Aerosol Med Pulm Drug Deliv201629321923226919553
- CarpenterDMRobertsCASageAJGeorgeJHorneRA review of electronic devices to assess inhaler techniqueCurr Allergy Asthma Rep20171731728290015
- UsmaniOSNew developments in inhaled drugs: within and beyond the lungsRespiration20148811224801444
- BiddiscombeMFUsmaniOSBarnesPJA system for the production and delivery of monodisperse salbutamol aerosols to the lungsInt J Pharm2003254224325312623200
- BerlinskiAPediatric aerosol therapyRespir Care201762666267728546371
- HamelmannESzeflerSJEfficacy and safety of tiotropium in children and adolescentsDrugs201878332733829368127
- BarronsRWheelerJWoodsJAOpportunities for inhaler device selection in elderly patients with asthma or COPDPatient Intelligence201575365
- ScichiloneNBraidoFLavoriniFLevyMLUsmaniOSRoutine use of budesonide/formoterol fixed dose combination in elderly asthmatic patients: practical considerationsDrugs Aging201734532133028258535